LabCompass

Michael R. Grever

Medicine · The Ohio State University

Established · publishing since 1980

Publications

487

Citations

35,263

Est. group size

~41

Recurring co-author estimate

Active years

47

Publishing since 1980

Research summary
AI-generated

Michael R. Grever's research centers on hairy cell leukemia and related blood cancers, focusing on clinical treatment approaches such as purine analog drugs, targeted BRAF inhibitors, and combination salvage therapies for patients who relapse. His work also examines drug side effects, dosing strategies, and updated clinical guidelines for diagnosing and managing this disease. This research is primarily clinical and translational, aimed at improving treatment outcomes for patients with this rare blood cancer.

Hairy cell leukemia treatmentTargeted cancer therapies (BRAF inhibitors)Chemotherapy drug development and pharmacokineticsClinical trial outcomes in blood cancersAdverse drug reactions in leukemia treatment

Publication output has grown substantially over the last decade, rising from roughly 9 papers per year in 2017 to a peak of 38 in 2023, though it has declined again in 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 14.6/year recently
2017: 9 publications172018: 7 publications182019: 8 publications192020: 14 publications202021: 8 publications212022: 20 publications222023: 38 publications38232024: 9 publications242025: 5 publications252026: 1 publication26
Publishes in
  • Blood×43
  • Leukemia×10
  • Journal of Clinical Oncology×9
  • Blood Advances×6
  • American Journal of Hematology×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile